Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9063201 | 0.75 | — | — | |
| SCHEMBL22133737 | 0.73 | — | — | |
| Hydrochloric Acid SCHEMBL9835591 | 0.73 | HSD17B10 (0.33) | HSD17B10TSHR | |
| SCHEMBL13535856 | 0.73 | LMNA (0.43) | HSD17B10 | |
| SCHEMBL13449837 | 0.71 | LMNA (0.41) | HSD17B10TSHR | |
| SCHEMBL15888713 | 0.71 | LMNA (0.41) | HSD17B10TSHR | |
| SCHEMBL30678638 | 0.71 | LMNA (0.41) | HSD17B10TSHR | |
| SCHEMBL24285433 | 0.71 | LMNA (0.41) | HSD17B10TSHR | |
| SCHEMBL16298991 | 0.71 | LMNA (0.41) | HSD17B10TSHR | |
| SCHEMBL12680283 | 0.71 | LMNA (0.41) | HSD17B10TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230020092-A1 | COMPOSITIONS FOR DELIVERY OF ANTISENSE COMPOUNDS | ENTRADA THERAPEUTICS, INC. | 2023-01-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230020092-A1 | COMPOSITIONS FOR DELIVERY OF ANTISENSE COMPOUNDS | HNRNPAB, SNRPE, HNRNPA2B1 | HSD17B10 4032/4885TSHR 2244/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.